The American Urological Association's Annual Meeting is one of the largest meetings of urological professionals in the world. More than 10,000 urologists and health care professionals and 350 exhibitors were expected in Anaheim.
At this year's meeting the AUA offered the largest number of scientific and instructional offerings in its history - there were plenary sessions, instrucional courses and hands-on sessions on surgical techniques, new technology, basic science or practice management.
We have talked to internationally renowned urologists about their view of the most interesting congress topics. Please select among the following video interviews:

Using PSA to evaluate risk of prostate cancer in young men. An interview with Professor W. J. Catalona, Chicago (US) at the AUA 2007

Recent data suggests that men in their 40s can be stratified for risk of prostate cancer based on their PSA score, which could potentially decrease the overall rate of biopsy.

Professor W. J. Catalona

Evaluating and treating lower urinary tract symptoms associated with BPH. An interview with Professor C. R. Chapple, Sheffield (GB) at the AUA 2007

This interview discussed the current status and future prospects for evaluation and treatment of LUTS associated with BPH and overactive bladder syndrome.

Professor C.R. Chapple

Optimising Androgen Suppression in Advanced Prostate Cancer. An interview with Professor K. Miller, Berlin (DE) at the AUA 2007

At a late breaking session at the AUA Professor Kurt Miller presented the results of a trial that compared intermittent to continuous androgen therapy in patients with advanced prostate cancer.

Professor K. Miller

Treating localised prostate cancer. An interview with Professor M. Wirth, Dresden (DE) at the AUA 2007

Urologists are increasingly treating localised prostate cancer as this disease is being detected at earlier stages by PSA screening programs. This interview discussed the current treatment options.

Professor M. Wirth